Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
4 Years
N/A
Both
Neoplasm
Trial Information
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
Background:
-This protocol will provide a means for screening potential candidates for NCI Radiation
Oncology Branch (ROB) protocols.
Objectives:
-To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to
identify individuals who will be suitable candidates for Radiation Oncology Branch clinical
research protocols.
Eligibility:
-Patients suspected of having, or with biopsy proven malignant disease or patients with a
benign condition for whom radiotherapy is a potential treatment.
Design:
-This is a screening protocol. No investigational treatments will be administered on this
protocol.
Inclusion Criteria
- INCLUSION CRITERIA:
Patients suspected of having, or with biopsy proven malignant disease or patients with a
benign condition for whom radiotherapy is a potential treatment.
Patient or guardian is able to provide informed consent.
EXCLUSION CRITERIA:
Candidates who do not meet the inclusion criteria.
Type of Study:
Observational
Study Design:
N/A
Principal Investigator
Kevin A Camphausen, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
National Cancer Institute (NCI)
Authority:
United States: Federal Government
Study ID:
000181
NCT ID:
NCT00026689
Start Date:
July 2000
Completion Date:
Related Keywords:
- Neoplasm
- Screening
- Cancer
- Neoplasms
Name | Location |
|---|---|
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda, Maryland 20892 |
